156 related articles for article (PubMed ID: 36661213)
41. Socioeconomic, lifestyle and biological determinants of cervical screening coverage: Lolland-Falster Health Study, Denmark.
Tabatabai MK; Lophaven S; Lauenborg J; Holmager T; Jepsen R; Lynge E
Eur J Public Health; 2023 Aug; 33(4):568-573. PubMed ID: 37295965
[TBL] [Abstract][Full Text] [Related]
42. Examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic: a mixed methods assessment.
Fuzzell L; Brownstein NC; Fontenot HB; Lake PW; Michel A; Whitmer A; Rossi SL; McIntyre M; Vadaparampil ST; Perkins RB
Elife; 2023 Sep; 12():. PubMed ID: 37656169
[TBL] [Abstract][Full Text] [Related]
43. Consequences of coronavirus disease-2019 (COVID-19) lockdown on infection-related hospitalizations among the pediatric population in Denmark.
Polcwiartek LB; Polcwiartek C; Andersen MP; Østergaard L; Broccia MD; Gislason GH; Køber L; Torp-Pedersen C; Schou M; Fosbøl E; Kragholm K; Hagstrøm S
Eur J Pediatr; 2021 Jun; 180(6):1955-1963. PubMed ID: 33555426
[TBL] [Abstract][Full Text] [Related]
44. Self-sampling in Human Papillomavirus screening during and post-COVID-19 pandemic.
Tan CS; Hamzah ND; Ismail ZHF; Jerip AR; Kipli M
Med J Malaysia; 2021 May; 76(3):298-303. PubMed ID: 34031326
[TBL] [Abstract][Full Text] [Related]
45. Cancer screening programmes in Italy during the COVID-19 pandemic: an update of a nationwide survey on activity volumes and delayed diagnoses.
Battisti F; Falini P; Gorini G; Sassoli de Bianchi P; Armaroli P; Giubilato P; Giorgi Rossi P; Zorzi M; Battagello J; Senore C; Zappa M; Mantellini P
Ann Ist Super Sanita; 2022; 58(1):16-24. PubMed ID: 35324470
[TBL] [Abstract][Full Text] [Related]
46. Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study.
Aitken CA; van Agt HME; Siebers AG; van Kemenade FJ; Niesters HGM; Melchers WJG; Vedder JEM; Schuurman R; van den Brule AJC; van der Linden HC; Hinrichs JWJ; Molijn A; Hoogduin KJ; van Hemel BM; de Kok IMCM
BMC Med; 2019 Dec; 17(1):228. PubMed ID: 31829241
[TBL] [Abstract][Full Text] [Related]
47. Preterm birth, stillbirth and early neonatal mortality during the Danish COVID-19 lockdown.
Hedley PL; Hedermann G; Hagen CM; Bækvad-Hansen M; Hjalgrim H; Rostgaard K; Laksafoss AD; Hoffmann S; Jensen JS; Breindahl M; Melbye M; Hviid A; Hougaard DM; Krebs L; Lausten-Thomsen U; Christiansen M
Eur J Pediatr; 2022 Mar; 181(3):1175-1184. PubMed ID: 34783897
[TBL] [Abstract][Full Text] [Related]
48. Non-participation in screening: the case of cervical cancer in Denmark.
Dugué PA; Lynge E; Bjerregaard B; Rebolj M
Prev Med; 2012; 54(3-4):266-9. PubMed ID: 22300964
[TBL] [Abstract][Full Text] [Related]
49. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
Thomsen LT; Kjaer SK; Munk C; Ørnskov D; Waldstrøm M
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):394-402. PubMed ID: 33566361
[TBL] [Abstract][Full Text] [Related]
50. Low adherence to cervical cancer screening after subtotal hysterectomy.
Andersen LL; Møller LM; Gimbel HM
Dan Med J; 2015 Dec; 62(12):A5165. PubMed ID: 26621394
[TBL] [Abstract][Full Text] [Related]
51. [HPV-Hr detection by home self sampling in women not compliant with pap test for cervical cancer screening. Results of a pilot programme in Bouches-du-Rhône].
Piana L; Leandri FX; Le Retraite L; Heid P; Tamalet C; Sancho-Garnier H
Bull Cancer; 2011 Jul; 98(7):723-31. PubMed ID: 21700548
[TBL] [Abstract][Full Text] [Related]
52. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
[TBL] [Abstract][Full Text] [Related]
53. Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general population.
Thorsteinsson K; Ladelund S; Jensen-Fangel S; Katzenstein TL; Johansen IS; Pedersen G; Junge J; Helleberg M; Storgaard M; Obel N; Lebech AM
HIV Med; 2016 Jan; 17(1):7-17. PubMed ID: 26058995
[TBL] [Abstract][Full Text] [Related]
54. Impact of invitation schemes on breast cancer screening coverage: A cohort study from Copenhagen, Denmark.
Jacobsen KK; von Euler Chelpin M; Vejborg I; Lynge E
J Med Screen; 2017 Mar; 24(1):20-26. PubMed ID: 27206815
[TBL] [Abstract][Full Text] [Related]
55. Self-assessed health, perceived stress and non-participation in breast cancer screening: A Danish cohort study.
Jensen LF; Pedersen AF; Andersen B; Vedsted P
Prev Med; 2015 Dec; 81():392-8. PubMed ID: 26494608
[TBL] [Abstract][Full Text] [Related]
56. Barriers to cervical cancer screening faced by immigrants: a registry-based study of 1.4 million women in Norway.
Leinonen MK; Campbell S; Ursin G; Tropé A; Nygård M
Eur J Public Health; 2017 Oct; 27(5):873-879. PubMed ID: 28957477
[TBL] [Abstract][Full Text] [Related]
57. Concurrent participation in breast, cervical, and colorectal cancer screening in the Netherlands.
Kregting LM; Olthof EMG; Breekveldt ECH; Aitken CA; Heijnsdijk EAM; Toes-Zoutendijk E; de Koning HJ; van Ravesteyn NT
Eur J Cancer; 2022 Nov; 175():180-186. PubMed ID: 36126478
[TBL] [Abstract][Full Text] [Related]
58. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
Machii R; Takahashi H
Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
[TBL] [Abstract][Full Text] [Related]
59. Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention.
Lönnberg S; Andreassen T; Engesæter B; Lilleng R; Kleven C; Skare A; Johansson K; Fredheim CS; Tropé A
BMJ Open; 2016 Nov; 6(11):e013728. PubMed ID: 28186949
[TBL] [Abstract][Full Text] [Related]
60. Differential effects of colorectal cancer screening across sociodemographic groups in Denmark: a register-based study.
Pallesen AVJ; Herrstedt J; Westendorp RGJ; Mortensen LH; Kristiansen M
Acta Oncol; 2021 Mar; 60(3):323-332. PubMed ID: 33427545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
